CD274 and cancer: Immunotherapy has revolutionized cancer treatment in the past decade, especially the successful application of immune checkpoint inhibitors (ICIs) therapy in clinical practices that mainly enhance the host immunity via blocking co‐inhibitory molecules like PD‐1 or PD‐L1 to improve the immune‐killing effect of T cells.